Please find enclosed herewith the details of the Analyst / Investor meeting to be held on 29th May,2026.
ALKEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Alkem Laboratories has disclosed a scheduled one-on-one in-person meeting with SBI Mutual Fund on 29th May 2026 in Mumbai. This is a routine regulatory disclosure under SEBI (LODR) Regulations, 2015, informing exchanges about an upcoming institutional investor interaction. The filing is dated 25th May 2026 and signed by Manish Narang, President – Legal, Company Secretary & Compliance Officer. No agenda, financial details, or investment recommendations were disclosed in this intimation.
This is a routine disclosure confirming institutional engagement with a major mutual fund. While it signals ongoing investor interest, it contains no material information that would directly impact the stock price.